Germany: Life Sciences 2017
We list 51 lawyers for their expertise in life sciences, including advising on the manufacturing, licensing and distribution of pharmaceuticals and medical products including issues relating to product liability litigation and patent licensing and protection.
|Most Highly Regarded Individuals|
|Burkhard Sträter||Sträter Rechtsanwälte, Bonn|
|Ina Brock||Hogan Lovells, Munich|
|Markus Ambrosius||Sträter Rechtsanwälte, Bonn|
|Andreas von Falck||Hogan Lovells, Düsseldorf|
|Christian Dierks||Dierks + Bohle, Berlin|
|Ulrich Reese||Clifford Chance, Düsseldorf|
|Frank-Erich Hufnagel||Freshfields Bruckhaus Deringer, Düsseldorf|
|Michael Molitoris||Noerr, Munich|
|Thomas Bopp||Gleiss Lutz, Düsseldorf|
|Joachim Feldges||Allen & Overy, Munich|
Taylor Wessing leads our research with five listed practitioners. Practice leader Manja Epping has advised pharmaceutical and biotech companies in a wide range of matters and focuses particularly on cross-border issues. She is “sharp-minded and able to break down complex issues in a way that clients can understand them”. Wolfgang Rehmann is recommended by peers for the expertise he provides to clients on the manufacture and distribution of pharmaceutical devices. Henning Moelle is a “very capable product liability lawyer” where he has a depth of expertise in medical devices and pharmaceuticals. Christoph de Coster is a standout lawyer in the life sciences field who specialises in patent infringement and invalidity claims. Sabine Rojahn is a highly experienced figure in the market who focuses on patent litigation in the pharmaceuticals industry.
Bird & Bird sees four lawyers listed. Head of the German IP group Christian Harmsen is highly experienced in IP and patent litigation relating to life sciences and is well reputed as “a dynamic lawyer with a depth of knowledge”. The “superb” Michael Alt is a patent attorney with a strong focus on biology, medical chemistry and medical machinery. He has experience representing clients in matters before both the German and European Patent Office. Matthias Meyer provides “exceptional expertise” in life sciences-related patent matters. Oliver Jan Jüngst provides a wealth of experience in patent infringement litigation in the life sciences and healthcare fields.
At Hogan Lovells four lawyers are recognised, two of whom are some of the highest regarded practitioners in our research. Ina Brock has experience advising global life sciences companies on issues of product liability and is described as “one of the most prominent product liability defence lawyers in Germany". Andreas von Falck is a “tenacious lawyer” who specialises in IP for multinational clients in the pharmaceutical and medical devices sector. Sebastian Lach’s practice features an emphasis on international product liability cases, often involving the life sciences sector. Jörg Schickert is a specialist in compliance and regulatory issues relating to pharmaceuticals, biotech and medical devices.
Sträter Rechtsanwälte sees two of its lawyers recommended as among our highest ranking practitioners. Founding partner Burkhard Sträter is “an expert in medicine and medical devices regulation” and has been advising on life sciences issues for over 30 years. Markus Ambrosius advises pharmaceutical companies on life sciences law Europe-wide, including cases before the European Court of Justice. He is described as being “at the absolute top” of the market. Isabelle Kotzenberg has experience in numerous areas of life sciences law, particularly in the pharmaceuticals arena, including contractual issues as well as expertise in product liability and medical devices matters.
At boutique firm Dr Schmidt-Felzmann & Kozianka, Wolfgang Kozianka focuses on drugs law, advertising, healthcare fraud, doctor’s law and healthcare policy. He “gives great advice across the whole gamut of life sciences law”. Simone Winnands is recognised for her longstanding experience in the practice. She has notable expertise in healthcare advertising matters.
Founding partner Alexander Ehlers of Ehlers Ehlers & Partner is once again recognised for his “peerless knowledge of pharmaceuticals law”. Karin Gräfin von Strachwitz-Helmstatt also has extensive expertise in medical law, with a focus on representing service providers. She has been practicing for over 20 years.
Gleiss Lutz sees Thomas Bopp named as one of the most highly nominated lawyers in our research. He is recommended for his skill in patent litigation relating to life sciences, where he is considered to be one of Germany’s foremost practitioners. Andreas Neun advises on public procurement and commercial law in the healthcare sector and has advised corporations and private funds around the world.
At Hoyng Rokh Monegier, Thomas Reimann has acted for clients before the national courts in IP matters, including patent litigation. He is “a seasoned expert who can always be counted on”. Christine Kanz is “extremely well-versed in IP matters” relating to life sciences. Among her areas of expertise are patent litigation and the drafting of license agreements for pharmaceutical and biotech companies.
Lützeler Klümper Rechtsanwälte founding partner Claudia Lützeler advises companies on pharmaceuticals, medical devices and biotechnology matters and is highly regarded for her acute knowledge of the area. Mathias Klümper has broad experience of life sciences law having worked both in private practice and as corporate counsel. He specialises in pharmaceuticals and medical devices mandates and is described by peers as "very active in the life sciences scene".
Rospatt Osten Pross Partnerschaftsgesellschaft sees Max von Rospatt listed as a “consummate expert” in various patent law issues covering areas including pharmaceuticals and genetic engineering. Thomas Musmann is recognised for his skills as a patent litigator in the pharmaceuticals, chemicals and biotech sectors.
Clifford Chance’s Ulrich Reese is one of the highest-regarded practitioners in our research. He is described as “a big name in the field” by his peers and advises national and international companies on the law of pharmaceuticals and medical devices, including market access and compliance. Peter Dieners is recommended for his “deep insight into life sciences; he is really focused on the area”.
At Freshfields, Frank-Erich Hufnagel is “scholarly in his approach” to patent enforcement and litigation of pharmaceuticals. He advises multinational companies and provides a deep understanding of the sector.
Joachim Feldges at Allen & Overy specialises in complex patent litigation in the pharmaceuticals and biotechnology spheres. He has nearly 30 years’ experience in the area.
Michael Molitoris at Noerr handles litigation and product liability and product safety issues in numerous jurisdictions. He is “a practical and highly effective lawyer”. Also at the firm is Thomas Klindt, who is “an expert in product liability law” and has extensive experience in this field relating to the life sciences sector.
Founding partner Christian Dierks of Dierks + Bohle is a “leading expert” in the life sciences sector and also possesses expertise in medical law and healthcare systems.